Larotrectinib

CAS: 1223403-58-4

Ref. 3D-FD145150

Información del producto

• Nombre: Larotrectinib
• Sinónimos: LOXO 101(3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamideARR Y 470
• Marca: Biosynth
• Descripción: A potent ATP-competitive inhibitor of tropomyosin-related kinases (TRK1, TRK2 and TRK3), members of the receptor tyrosine kinase family of neurotrophin receptors. Tumors with oncogenic TRK fusions are sensitive to larotrectinib, leading to reduced proliferation and tumor growth in patients with soft tissue sarcoma, triple-negative breast cancer and lung cancer.

Propiedades químicas

• Peso molecular: 428.44 g/mol
• Fórmula: C₂₁H₂₂F₂N₆O₂
• Pureza: Min. 98 Area-%
• Color/Forma: Yellow Powder
• InChI: InChI=1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31)/t14-,18+/m0/s1
• Clave InChI: InChIKey=NYNZQNWKBKUAII-KBXCAEBGSA-N
• SMILES: O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1